Targeting Core
瞄准核心
基本信息
- 批准号:7983111
- 负责人:
- 金额:$ 18.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAmino AcidsAntibodiesAptamer TechnologyAreaBindingBinding ProteinsBiologicalBiological MarkersCCNE1 geneCD44 geneCell Membrane ProteinsCell surfaceCellsChemistryComplexDiversity LibraryE-SelectinEpidermal Growth Factor ReceptorExhibitsGoldHIV-1In VitroIntercellular adhesion molecule 1Legal patentLibrariesLifeLigandsMethodsModificationMolecular WeightNucleic Acid FoldingNucleic AcidsNucleocapsidOligonucleotidesOxygenPeptide antibodiesPeptide aptamersPeptidesPhage DisplayPharmaceutical PreparationsPhosphorothioate OligonucleotidePreparationPropertyProteinsPublicationsRNAReagentResourcesRicinSideSolutionsSpecificityStem cellsStructureSulfurSurfaceTechnologyTemperatureTimeToxinVertebral columnanalogaptamerbasecancer stem cellcombinatorialcostenv Gene Productsfunctional groupimmunogenicityinorganic phosphateinterestmeetingsnanoparticlenext generationnovelnucleasephosphate esterscaffoldsmall moleculethiophosphate
项目摘要
CORE TITLE: Targeting Core
CORE SUMMARY: Traditionally, robust protein-specific targeting ligand requirements are met by antibodies (Abs). Antibodies however often have significant problems, including high cost, selection difficulties, selectivity problems, preparation difficulties, stability and immunogenicity. The Targeting Core objective is to provide the Projects in the TCCN sets of targeting reagents for the nanoparticles that not only includes "gold standard" antibodies but novel aptamers and peptides to both endothelial, cancer and stem cells, both to specific cell surface ligands as well as the cells themselves. All projects will use the resources from the Biological Targeting Core. Specifically, the Targeting Core will develop thioaptamers and next-generation Xaptamers for targeting nanoparticles to CD44 (Project 1; Aim 2), E-Selectin, (Project 1: Aim 2, Project 2: Aim 2), VGFR, EGFR, ICAM-1 and cells (Project 3: Aim 1) and peptides and antibodies via phage display for targeting proteins (Project 1; Aim 2) and cells (Project 3: Aim 1; Project 4: Aim 2). Additionally, the Targeting Core will provide conjugation of targeting ligands and all micro/nanoparticles (Projects 1-3).
核心标题:瞄准核心
核心摘要:传统上,抗体(Abs)满足稳健的蛋白质特异性靶向配体要求。然而,抗体通常具有显著的问题,包括高成本、选择困难、选择性问题、制备困难、稳定性和免疫原性。靶向核心目标是为纳米颗粒提供TCCN靶向试剂组中的项目,这些纳米颗粒不仅包括“金标准”抗体,还包括针对内皮细胞、癌症细胞和干细胞的新型适体和肽,既针对特定的细胞表面配体,也针对细胞本身。所有项目都将使用生物靶向核心的资源。具体来说,靶向核心将开发硫代适体和下一代Xaptamers,用于将纳米颗粒靶向CD 44(项目1;目标2),E-选择素,(项目1:目标2,项目2:目标2)、VGFR、EGFR、ICAM-1和细胞(项目3:Aim 1)和肽和抗体通过噬菌体展示用于靶向蛋白质(项目1; Aim 2)和细胞(项目3:Aim 1;项目4:Aim 2)。此外,靶向核心将提供靶向配体和所有微米/纳米颗粒的缀合(项目1-3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David G Gorenstein其他文献
David G Gorenstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David G Gorenstein', 18)}}的其他基金
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS
用于选择最佳适体结合剂的大颗粒分选
- 批准号:
8361771 - 财政年份:2011
- 资助金额:
$ 18.19万 - 项目类别:
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS
用于选择最佳适体结合剂的大颗粒分选
- 批准号:
8169407 - 财政年份:2010
- 资助金额:
$ 18.19万 - 项目类别:
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS
用于选择最佳适体结合剂的大颗粒分选
- 批准号:
7956790 - 财政年份:2009
- 资助金额:
$ 18.19万 - 项目类别:
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS
用于选择最佳适体结合剂的大颗粒分选
- 批准号:
7724269 - 财政年份:2008
- 资助金额:
$ 18.19万 - 项目类别:
Role of Nitric Oxide and Cyclic GMP in Stem Cells
一氧化氮和环鸟苷酸在干细胞中的作用
- 批准号:
7623532 - 财政年份:2007
- 资助金额:
$ 18.19万 - 项目类别:
Role of Nitric Oxide and Cyclic GMP in Stem Cells
一氧化氮和环鸟苷酸在干细胞中的作用
- 批准号:
7872757 - 财政年份:2007
- 资助金额:
$ 18.19万 - 项目类别:
Combinatorial Selection of Beta-Catenin/T Cell Factor Pathway Inhibitors
β-连环蛋白/T 细胞因子通路抑制剂的组合选择
- 批准号:
7279882 - 财政年份:2006
- 资助金额:
$ 18.19万 - 项目类别:
Computational and Structural Biology in Biodefense
生物防御中的计算和结构生物学
- 批准号:
7274687 - 财政年份:2005
- 资助金额:
$ 18.19万 - 项目类别:
Computational and Structural Biology in Biodefense
生物防御中的计算和结构生物学
- 批准号:
7112261 - 财政年份:2005
- 资助金额:
$ 18.19万 - 项目类别:
Computational and Structural Biology in Biodefense
生物防御中的计算和结构生物学
- 批准号:
6949320 - 财政年份:2005
- 资助金额:
$ 18.19万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 18.19万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 18.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别: